متابعة القراءة
المقال الكامل على Bloomberg
Keurig Dr Pepper Soars; Carter's Falls; Avidity Biosciences Rallies
{# Share Buttons Partial Variables: share_title — text to pre-fill in share dialogs share_url — canonical URL to share (use request.build_absolute_uri in parent) #}تحليل معلومات السوق
مدعوم بالذكاء الاصطناعي
لماذا هذا مهم
Keurig Dr Pepper's shares surged due to revised sales growth expectations and a $7 billion funding deal, while Carter's shares fell after missing sales estimates and announcing job cuts and store closures. Avidity Biosciences' shares rallied after being acquired by Novartis for $12 billion.
تأثير السوق
Market impact analysis based on bullish sentiment with 85% confidence.
المشاعر
Bullish
ثقة الذكاء الاصطناعي
85%
سياق المقال
ملاحظة: هذا مقتطف موجز للسياق. انقر أدناه لقراءة المقال الكامل على المصدر الأصلي.
On this episode of Stock Movers with Lisa Mateo: - Keurig Dr Pepper (KDP) shares soared ahead of the New York open after the company announced it now expects fiscal 2025 constant currency net sales growth in a high-single-digit range, revised from a mid-single-digit growth outlook previously. KDP also announced it is raising $7 billion from Apollo and KKR to help finance its acquisition of JDE Peet’s NV, aiming to ease investor concerns about taking on too much debt. - Carter's (CRI) shares fall ahead of the open after the children’s apparel company reported net sales for the third quarter that missed the average analyst estimate. The company also plans to reduce offices-based roles by about 15% by the end of 2025, and it boosted the amount of stores it plans to close. - Avidity Biosciences (RNA) shares rally in premarket trading after Novartis (NOVN) agreed to buy the biotechnology company in a deal valued at $12 billion. (Source: Bloomberg)
المقال الأصلي منشور بواسطة
Bloomberg
في أكتوبر 27, 2025.
التحليل والرؤى المقدمة من AnalystMarkets AI.
التحليل والرؤى المقدمة من AnalystMarkets AI.